<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Anesthetic management for enhanced recovery after thoracic surgery</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Anesthetic management for enhanced recovery after thoracic surgery</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Anesthetic management for enhanced recovery after thoracic surgery</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Wanda M Popescu, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Katherine A Michelini, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Peter D Slinger, MD, FRCPC</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Nancy A Nussmeier, MD, FAHA</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jul 05, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H922997053"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Enhanced recovery after surgery (ERAS) refers to multimodal multidisciplinary standardization of perioperative care to minimize responses to surgical stress and postoperative pain, expedite recovery, decrease hospital length of stay, reduce complications, and improve outcomes following elective procedures. This topic discusses elements of medical and anesthetic management specific for enhanced recovery after thoracic surgery (ERATS).</p><p>Separate topics address ERAS for cardiac surgery and major noncardiac procedures:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/126472.html" rel="external">"Anesthetic management for enhanced recovery after cardiac surgery (ERACS)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/113724.html" rel="external">"Anesthetic management for enhanced recovery after major noncardiac surgery (ERAS)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/15006.html" rel="external">"Enhanced recovery after colorectal surgery"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/113714.html" rel="external">"Enhanced recovery after gynecologic surgery: Components and implementation"</a>.)</p><p></p><p class="headingAnchor" id="H3273346626"><span class="h1">SCOPE AND GOALS OF ERATS PROGRAMS</span><span class="headingEndMark"> — </span>Key recommendations for medical, anesthetic, and surgical management in enhanced recovery after thoracic surgery (ERATS) programs address the entire pathway from preoperative consultation to hospital discharge [<a href="#rid1">1</a>]. Specific goals include reducing opioid use, length of stay in the intensive care unit (ICU) and hospital, morbidity (particularly pulmonary and cardiac morbidity), and costs. Studies of implementation of ERATS protocols for lung resection include [<a href="#rid1">1-8</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>A 2017 meta-analysis of seven randomized trials included 486 patients undergoing lung resection [<a href="#rid7">7</a>]. ERATS patients had lower overall morbidity (risk ratio [RR] 0.64, 95% CI 0.51-0.80), particularly rates of pulmonary (RR 0.43, 95% CI 0.31-0.60) and surgical complications (RR 0.46, 95% CI 0.25-0.83) compared with control group patients. Cardiovascular complications and in-hospital mortality were similar in the groups. Five of the seven trials reported shortened ICU and hospital length of stay in patients enrolled in an ERATS protocol, although significant heterogeneity was noted among studies [<a href="#rid7">7</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A 2021 prospective study compared 169 patients undergoing pulmonary resection before implementation of an ERATS protocol with 126 patients after implementation [<a href="#rid2">2</a>]. After implementation of their ERATS protocol, the investigators noted increased use of minimally invasive surgery (62.7 versus 39.6 percent), reduced ICU utilization (21.4 versus 70.4 percent), improved early removal of chest tubes (54.8 versus 24.3 percent) and urinary catheters (65.1 versus 20.1 percent) by postoperative day one, and improved success with ambulation at least three times on postoperative day one (54.8 versus 46.8 percent). Decreased opioid use (101 versus 82 daily oral <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">morphine</a> equivalents, 95% CI 1-36), and direct costs of hospitalization were noted [<a href="#rid2">2</a>]. Furthermore, an overall decrease in the incidence of morbid events was noted (32 to 20 percent, 95% CI 1.6-22.5 percent). These included delirium, atrial fibrillation, myocardial infarction, atelectasis, pneumothorax, pleural effusion, respiratory failure, air leak, renal failure, venous thromboembolism, blood transfusion, pneumonia, surgical site infection, urinary tract infection, and sepsis. Readmission was similar before and after implementation of the ERATS protocol, even though discharge had been expedited resulting in a shorter length of stay in the hospital (4.4 versus 3.2 days, 95% CI 0.3-2.0 days) [<a href="#rid2">2</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A 2018 review of 2886 lung resections noted that the implementing a full ERATS protocol after open thoracotomy was associated with decreased pulmonary and cardiac complications, as well as decreased hospital length of stay (pre-ERATS, n = 1615; transitional period, n = 929; full ERATS protocol, n = 342) [<a href="#rid3">3</a>]. However, there was little change in these outcomes after minimally invasive video-assisted thoracic surgery procedures. ERATS did not affect hospital readmission after either surgical procedure type [<a href="#rid3">3</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A 2018 study comparing outcomes in minimally invasive video-assisted thoracic surgery lung resections before (n = 162) and after (n = 81) implementation of an ERATS protocols noted shortened hospital length of stay, decreased opioid usage, minimized fluid overload, and decreased hospital costs in the first year following implementation [<a href="#rid4">4</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A 2015 retrospective study in open lung resection comparing outcomes before (n = 127 patients) and after (n = 107 patients) implementation of an ERATS protocol noted decreased overall incidence of complications from 64 to 37 percent, in particular urinary tract infections (3 versus 15 percent]) [<a href="#rid6">6</a>]. Hospital length of day also decreased after implementation of the protocol from a median of 7 days (interquartile range [IQR] 6 to 10 days) to a median of 6 days (IQR 5 to 7 days) in ERATS patients. The incidence of hospital readmission was similar between groups [<a href="#rid6">6</a>].</p><p></p><p>However, results demonstrating improvements after implementation of ERATS protocols are not consistent [<a href="#rid9">9</a>]. As with other types of major surgery, positive effects of ERATS protocols for patients undergoing pulmonary resection are greatest when high compliance with all elements of the pathway is achieved rather than implementing one or two elements in isolation [<a href="#rid1">1,3,5,8</a>].</p><p class="headingAnchor" id="H2793476726"><span class="h1">PREOPERATIVE STRATEGIES</span></p><p class="headingAnchor" id="H3515787562"><span class="h2">Anemia management</span><span class="headingEndMark"> — </span>Anemia should be always be identified in the preoperative period in time to correct reversible causes (eg, iron deficiency) prior to elective thoracic surgery  (<a class="graphic graphic_algorithm graphicRef120496" href="/z/d/graphic/120496.html" rel="external">algorithm 1</a>) [<a href="#rid1">1</a>]. Notably, anemia is associated with adverse outcomes in patients undergoing lung resection for cancer, even after perioperative correction with blood transfusion [<a href="#rid10">10,11</a>]. (See  <a class="medical medical_review" href="/z/d/html/94347.html" rel="external">"Perioperative blood management: Strategies to minimize transfusions", section on 'Treatment of anemia'</a>.)</p><p class="headingAnchor" id="H1256328422"><span class="h2">Smoking cessation</span><span class="headingEndMark"> — </span>Smoking cessation is important to minimize postoperative complications after thoracic surgery, particularly before pulmonary resection for lung cancer because of the need for one lung ventilation and the loss of lung tissue. Smoking cessation may also decrease long-term mortality [<a href="#rid12">12</a>]. (See  <a class="medical medical_review" href="/z/d/html/6970.html" rel="external">"Strategies to reduce postoperative pulmonary complications in adults", section on 'Smoking cessation'</a>.)</p><p>Many of these patients have a smoking history (and may be active smokers). Ideally, smoking should stop at least four weeks before thoracic surgery [<a href="#rid1">1,13</a>]. Strategies are discussed in another topic. (See  <a class="medical medical_review" href="/z/d/html/127216.html" rel="external">"Smoking or vaping: Perioperative management", section on 'Helping perioperative patients quit smoking or vaping'</a>.)</p><p class="headingAnchor" id="H3153847768"><span class="h2">Prehabilitation in selected patients</span><span class="headingEndMark"> — </span>Prehabilitation in selected patients with poor nutrition and poor pulmonary function can optimize functional status, enhance recovery, and improve postoperative outcomes. Details are discussed in a separate topic. (See  <a class="medical medical_review" href="/z/d/html/120301.html" rel="external">"Overview of prehabilitation for surgical patients", section on 'Nutritional supplementation'</a> and  <a class="medical medical_review" href="/z/d/html/120301.html" rel="external">"Overview of prehabilitation for surgical patients", section on 'Physical exercise programs'</a>.)</p><p class="headingAnchor" id="H2535142569"><span class="h2">Patient education</span><span class="headingEndMark"> — </span>Patient and family education during the preoperative anesthetic consultation emphasizes expectations for early extubation, postoperative pain relief, and expedited recovery and discharge from the hospital. (See  <a class="medical medical_review" href="/z/d/html/126472.html" rel="external">"Anesthetic management for enhanced recovery after cardiac surgery (ERACS)", section on 'Preanesthetic consultation'</a> and  <a class="medical medical_review" href="/z/d/html/113724.html" rel="external">"Anesthetic management for enhanced recovery after major noncardiac surgery (ERAS)", section on 'Preanesthesia consultation'</a>.)</p><p class="headingAnchor" id="H1440883033"><span class="h1">DAY OF SURGERY STRATEGIES</span></p><p class="headingAnchor" id="H1496461060"><span class="h2">Limit fasting</span><span class="headingEndMark"> — </span>Clear fluids should be allowed up until two hours before and solids until six hours before induction of anesthesia, similar to enhanced recovery after surgery (ERAS) protocols for other types of surgery. Oral carbohydrate loading reduces postoperative insulin resistance and should be used routinely. (See  <a class="medical medical_review" href="/z/d/html/15006.html" rel="external">"Enhanced recovery after colorectal surgery", section on 'Fasting guidelines'</a>.)</p><p class="headingAnchor" id="H4222992019"><span class="h2">Avoid benzodiazepine premedication</span><span class="headingEndMark"> — </span>We avoid or minimize preoperative benzodiazepine anxiolytics including <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">midazolam</a> [<a href="#rid6">6,14</a>]. As discussed in separate topics, perioperative benzodiazepine administration may lead to oversedation, upper airway obstruction, and postoperative cognitive dysfunction and delirium. (See  <a class="medical medical_review" href="/z/d/html/113724.html" rel="external">"Anesthetic management for enhanced recovery after major noncardiac surgery (ERAS)", section on 'Medications administered in the preoperative period'</a> and  <a class="medical medical_review" href="/z/d/html/118691.html" rel="external">"Perioperative neurocognitive disorders in adults: Risk factors and mitigation strategies", section on 'Intravenous agents associated with higher risk'</a>.)</p><p class="headingAnchor" id="H3525576651"><span class="h1">INTRAOPERATIVE STRATEGIES</span></p><p class="headingAnchor" id="H3554791395"><span class="h2">Use of minimally invasive surgical procedures</span><span class="headingEndMark"> — </span>When feasible, a minimally invasive technique such as video-assisted thoracoscopic surgery rather than open thoracotomy is employed to decrease surgical trauma and postoperative pain in patients participating in enhanced recovery after thoracic surgery (ERATS) protocols [<a href="#rid1">1</a>]. (See  <a class="medical medical_review" href="/z/d/html/15141.html" rel="external">"Overview of minimally invasive thoracic surgery"</a> and  <a class="medical medical_review" href="/z/d/html/94263.html" rel="external">"Anesthesia for video-assisted thoracoscopic surgery (VATS) for pulmonary resection"</a>.)</p><p class="headingAnchor" id="H1598288904"><span class="h2">Use of short-acting anesthetic agents</span><span class="headingEndMark"> — </span>Short-acting intravenous (IV) and/or inhalation anesthetic agents as well as short-acting muscle relaxants are selected to facilitate early emergence and extubation. (See  <a class="medical medical_review" href="/z/d/html/113724.html" rel="external">"Anesthetic management for enhanced recovery after major noncardiac surgery (ERAS)", section on 'Maintenance of anesthesia'</a> and  <a class="medical medical_review" href="/z/d/html/94535.html" rel="external">"Clinical use of neuromuscular blocking agents in anesthesia"</a>.)</p><p class="headingAnchor" id="H2599292631"><span class="h2">Multimodal pain management</span><span class="headingEndMark"> — </span>Moderate-to-severe pain is common after thoracotomy due to the surgical incision, muscle retraction, rib spreading, and opening of the pleural space, which can result in injury to sternocostal and costovertebral joints and intercostal nerves [<a href="#rid15">15</a>]. We agree with the Society of Cardiovascular Anesthesiologists (SCA) recommendations to use customized multimodal opioid-sparing strategies to effectively control postoperative pain, which promotes recovery by allowing early mobilization and reducing risk for pulmonary complications, and potentially prevents development of persistent postoperative pain [<a href="#rid15">15</a>]. Strategies to limit use of opioids include combinations of neuraxial analgesia and regional nerve blocks, as well as administration of nonopioid analgesics [<a href="#rid1">1,15-17</a>]. These strategies are similar to those for enhanced recovery after other types of major surgery. (See  <a class="medical medical_review" href="/z/d/html/113724.html" rel="external">"Anesthetic management for enhanced recovery after major noncardiac surgery (ERAS)", section on 'Management of pain'</a>.)</p><p>Notably, thoracic surgery is associated with greater postoperative pain than most other major surgical procedures. Although the pathogenesis of pain after thoracic pain is complex, factors increasing postsurgical pain perception include stimulation of several nociceptive signals due to skin incision, muscle division, rib fracturing or spreading, rib disarticulation, costochondral joint disarticulation, bronchial resection, and pleural incision [<a href="#rid18">18</a>]. These multiple nociceptive signals amplify pain transmission and cause central sensitization.</p><p>Adequate pain management is necessary to avoid complications such as ineffective cough leading to poor clearing of secretions, development of hypoxemia and hypercarbia, and pain-induced sympathetic stimulation leading to arrhythmias and myocardial ischemia. Furthermore, meta-analyses suggest that one-half to one-third of patients experience pain at three and six months after thoracotomy [<a href="#rid19">19,20</a>]. Some develop a chronic postthoracotomy pain syndrome, often with a primary neuropathic component that becomes unresponsive to opioid medication [<a href="#rid17">17,20</a>].</p><p class="headingAnchor" id="H3527044166"><span class="h3">Regional anesthetic techniques</span><span class="headingEndMark"> — </span>We use regional anesthetic techniques for ERATS protocols. The most common techniques are thoracic epidural analgesia, paravertebral block, fascial plane blocks (eg, erector spinae block, serratus anterior plane block), or intercostal nerve blocks [<a href="#rid1">1,15</a>]. These are described in separate topics:</p><p class="bulletIndent1"><span class="glyph">●</span>Thoracic epidural analgesia (see  <a class="medical medical_review" href="/z/d/html/94261.html" rel="external">"Anesthesia for open pulmonary resection", section on 'Thoracic epidural analgesia'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Paravertebral block (see  <a class="medical medical_review" href="/z/d/html/126309.html" rel="external">"Thoracic paravertebral block procedure guide"</a> and  <a class="medical medical_review" href="/z/d/html/94261.html" rel="external">"Anesthesia for open pulmonary resection", section on 'Paravertebral block'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Thoracic nerve block techniques</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Erector spinae block (see  <a class="medical medical_review" href="/z/d/html/138905.html" rel="external">"Erector spinae plane block procedure guide"</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Serratus anterior plane block (see  <a class="medical medical_review" href="/z/d/html/100071.html" rel="external">"Thoracic nerve block techniques", section on 'Serratus plane block'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Intercostal nerve blocks (see  <a class="medical medical_review" href="/z/d/html/100071.html" rel="external">"Thoracic nerve block techniques", section on 'Intercostal nerve block'</a>)</p><p></p><p class="headingAnchor" id="H2161656084"><span class="h3">Nonopioid analgesics</span><span class="headingEndMark"> — </span>Minimizing opioids is an important component of multimodal analgesic strategies [<a href="#rid1">1,15</a>]. Systemically administered nonopioid analgesics typically used in ERATS protocols include (see  <a class="medical medical_review" href="/z/d/html/113724.html" rel="external">"Anesthetic management for enhanced recovery after major noncardiac surgery (ERAS)", section on 'Management of pain'</a> and  <a class="medical medical_review" href="/z/d/html/135261.html" rel="external">"Postoperative care after cardiac surgery", section on 'Analgesia'</a>):</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Acetaminophen</strong> – Oral or IV <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">acetaminophen</a> is a common component of pain management after thoracic surgery, particularly in combination with nonsteroidal anti-inflammatory drugs (NSAIDs), since acetaminophen reduces opioid consumption and has limited contraindications or adverse side effects [<a href="#rid1">1,15,21,22</a>]. Typically, we administer 1000 mg po before surgery, plus 1000 mg IV in the operating room if the duration of surgery is longer than six hours.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>NSAIDs</strong> – NSAIDs can improve postthoracotomy pain and limit opioid consumption [<a href="#rid1">1,15,22-24</a>]. A limited dose of an NSAID may be administered for a limited duration in patients who are not at risk for significant bleeding or acute kidney injury, usually in combination<strong> </strong>with <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">acetaminophen</a>. We typically administer preoperative oral <a class="drug drug_general" data-topicid="8847" href="/z/d/drug information/8847.html" rel="external">celecoxib</a> 200 mg po or IV <a class="drug drug_general" data-topicid="8591" href="/z/d/drug information/8591.html" rel="external">ketorolac</a> 15 mg at the end of surgery.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dexmedetomidine</strong> – <a class="drug drug_general" data-topicid="8897" href="/z/d/drug information/8897.html" rel="external">Dexmedetomidine</a> is an alpha-2 agonist with sedative and anesthetic-sparing properties that is associated with improved postoperative pain scores, and with reduced opioid requirements and respiratory complications after cardiothoracic surgery [<a href="#rid1">1,15,25</a>].</p><p></p><p><a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">Ketamine</a> is an N-methyl-D-aspartate (NMDA) receptor antagonist that is of uncertain benefit but is used in subanesthetic doses in some ERATS protocols to reduce <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">morphine</a> consumption and improve early postoperative lung function, particularly in patients with opioid tolerance [<a href="#rid1">1,15,26</a>]. Other agents of uncertain benefit that are used in some centers include magnesium and <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> [<a href="#rid15">15</a>].</p><p class="headingAnchor" id="H2579391733"><span class="h3">Opioid analgesics</span><span class="headingEndMark"> — </span>Limited use of opioids may be necessary to provide effective analgesia, prevent splinting, and enable passive expiration in the immediate postoperative period [<a href="#rid15">15</a>]. We typically administer doses of <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a> during the intraoperative period. If necessary, we administer oral <a class="drug drug_general" data-topicid="9729" href="/z/d/drug information/9729.html" rel="external">oxycodone</a> in the early postoperative period (usually in combination with <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">acetaminophen</a> and an NSAID). However, opioid use is limited due to risk of respiratory depression after thoracic surgery, particularly in older patients or those with pre-existing pulmonary conditions such as chronic obstructive pulmonary disease. (See  <a class="medical medical_review" href="/z/d/html/113724.html" rel="external">"Anesthetic management for enhanced recovery after major noncardiac surgery (ERAS)", section on 'Opioids'</a>.)</p><p>Another concern is persistent postoperative opioid and chronic opioid dependence after a painful thoracic surgical procedure. Persistent opioid use is associated with poor compliance with postoperative treatment, increased postoperative morbidity including cardiovascular risk, and decreased overall survival (particularly cancer-specific survival) [<a href="#rid27">27</a>].</p><p class="headingAnchor" id="H4164880078"><span class="h2">Lung protective ventilation</span><span class="headingEndMark"> — </span>Risks associated with one lung ventilation include hypoxemia and ventilator-associated lung injury due to volutrauma and oxidative stress in the ventilated lung and atelectasis in the nonventilated lung [<a href="#rid28">28</a>]. Lung-protective ventilation strategies are employed to minimize iatrogenic lung injury to minimize iatrogenic lung injury during periods of ventilation of one or both lungs [<a href="#rid1">1,29,30</a>]. Details are available in separate topics. (See  <a class="medical medical_review" href="/z/d/html/14945.html" rel="external">"One lung ventilation: General principles", section on 'Lung-protective ventilation strategies'</a> and  <a class="medical medical_review" href="/z/d/html/93386.html" rel="external">"Mechanical ventilation during anesthesia in adults", section on 'Lung protective ventilation during anesthesia'</a>.)</p><p class="headingAnchor" id="H1648162078"><span class="h2">Maintenance of normovolemia</span><span class="headingEndMark"> — </span>A "moderate," goal-directed fluid management strategy (rather than a restrictive or liberal fluid management strategy) is employed to maintain normovolemia (ie, euvolemia). A balanced crystalloid solution is selected, and we typically use dynamic parameters to determine fluid responsiveness. Accumulating evidence suggests that carefully titrated goal-directed fluid therapy may decrease postoperative complications and length of stay [<a href="#rid1">1,31</a>]. Although very restrictive limitation of crystalloid solutions may facilitate early extubation and reduce pulmonary complications, concern for hypovolemia with impaired tissue perfusion and acute kidney injury has led to development of moderate goal-directed strategies to maintain euvolemia as a component of ERATS protocols [<a href="#rid1">1</a>]. However, we avoid excessive fluid administration (ie, &gt;3 L during the 24-hour perioperative period) because patients undergoing thoracic surgery are at increased risk for interstitial and alveolar edema due to existing pulmonary disease, prior chemoradiation, duration of one lung ventilation, direct lung manipulation, and ischemia-reperfusion injury. Excessive fluid administration is associated with worsening of acute lung injury and delayed recovery [<a href="#rid32">32-41</a>]. (See  <a class="medical medical_review" href="/z/d/html/14942.html" rel="external">"Intraoperative fluid management", section on 'Goal-directed fluid therapy'</a> and  <a class="medical medical_review" href="/z/d/html/14942.html" rel="external">"Intraoperative fluid management", section on 'Dynamic parameters to assess volume responsiveness'</a> and  <a class="medical medical_review" href="/z/d/html/94261.html" rel="external">"Anesthesia for open pulmonary resection", section on 'Fluid and hemodynamic management'</a>.)</p><p class="headingAnchor" id="H2221855633"><span class="h2">Maintenance of normothermia</span><span class="headingEndMark"> — </span>We fastidiously maintain temperature near normothermia (≥35.5°C) throughout the perioperative period [<a href="#rid1">1</a>]. (See  <a class="medical medical_review" href="/z/d/html/94588.html" rel="external">"Perioperative temperature management"</a>.)</p><p class="headingAnchor" id="H1603836492"><span class="h2">Postoperative nausea and vomiting prophylaxis</span><span class="headingEndMark"> — </span>In additional to use of opioid-sparing anesthetic techniques (see <a class="local">'Multimodal pain management'</a> above), we routinely administer a 5-hydroxytryptamine type 3 (5-HT3) antagonist such as IV <a class="drug drug_general" data-topicid="9719" href="/z/d/drug information/9719.html" rel="external">ondansetron</a> 4 mg and a glucocorticoid such as <a class="drug drug_general" data-topicid="9334" href="/z/d/drug information/9334.html" rel="external">dexamethasone</a> as part of multimodal postoperative nausea and vomiting prophylaxis [<a href="#rid1">1</a>]. For patients with history of postoperative nausea and vomiting or strong risk factors, we use a total IV anesthesia and avoid inhalation agents during surgery. (See  <a class="medical medical_review" href="/z/d/html/113724.html" rel="external">"Anesthetic management for enhanced recovery after major noncardiac surgery (ERAS)", section on 'Antiemetic prophylaxis'</a> and  <a class="medical medical_review" href="/z/d/html/16849.html" rel="external">"Postoperative nausea and vomiting", section on 'Prevention'</a>.)</p><p class="headingAnchor" id="H1552117423"><span class="h2">Early extubation</span><span class="headingEndMark"> — </span>Most patients are extubated in the operating room at end of the thoracic surgical procedure as described in separate topics. (See  <a class="medical medical_review" href="/z/d/html/94261.html" rel="external">"Anesthesia for open pulmonary resection", section on 'Emergence and postoperative airway management'</a> and  <a class="medical medical_review" href="/z/d/html/94265.html" rel="external">"Anesthesia for esophagectomy and other esophageal surgery", section on 'Emergence and extubation'</a>.)</p><p>Selected patients may need a period of postoperative controlled mechanical ventilation, particularly those with poor preoperative pulmonary function or those who required significant intraoperative pulmonary resection or administration of large volumes of fluid or blood.</p><p class="headingAnchor" id="H3496440477"><span class="h1">POSTOPERATIVE STRATEGIES</span></p><p class="headingAnchor" id="H3579611503"><span class="h2">Early postoperative mobilization</span><span class="headingEndMark"> — </span>As with enhanced recovery after other major surgical procedures, early postoperative mobilization is encouraged to reduce the risk of postoperative pneumonia and venous thromboembolism. For thoracic surgical patients, early removal of the chest tube and urinary catheter is particularly important to facilitate early mobility [<a href="#rid1">1</a>]. (See  <a class="medical medical_review" href="/z/d/html/15006.html" rel="external">"Enhanced recovery after colorectal surgery", section on 'Early mobilization'</a> and  <a class="medical medical_review" href="/z/d/html/135261.html" rel="external">"Postoperative care after cardiac surgery", section on 'Mobility'</a>.)</p><p class="headingAnchor" id="H1484667286"><span class="h2">Early enteral hydration and nutrition</span><span class="headingEndMark"> — </span>As with other major surgical procedures, early resumption of a diet and oral hydration within a few hours after surgery is optimal [<a href="#rid1">1</a>]. (See  <a class="medical medical_review" href="/z/d/html/15006.html" rel="external">"Enhanced recovery after colorectal surgery", section on 'Diet'</a>.)</p><p class="headingAnchor" id="H3094645830"><span class="h2">Venous thromboembolism prophylaxis</span><span class="headingEndMark"> — </span>Prophylactic measures to reduce the incidence of venous thromboembolism are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1339.html" rel="external">"Prevention of venous thromboembolic disease in adult nonorthopedic surgical patients"</a>.)</p><p class="headingAnchor" id="H3208975810"><span class="h2">Atrial fibrillation prevention</span><span class="headingEndMark"> — </span>Postoperative atrial fibrillation (AF) occurs in 12 to 44 percent of patients after thoracic surgery, and is associated with increased risk of pulmonary complications, hospital length of stay, and mortality [<a href="#rid1">1,42</a>]. Professional society guidelines for prophylaxis and treatment of AF include continuing chronically administered beta-blockers, ensuring adequate magnesium levels with magnesium supplementation when appropriate, and considering administration of prophylactic medications for high-risk patients who are not taking beta-blockers (eg, preoperative <a class="drug drug_general" data-topicid="9365" href="/z/d/drug information/9365.html" rel="external">diltiazem</a> or postoperative <a class="drug drug_general" data-topicid="8595" href="/z/d/drug information/8595.html" rel="external">amiodarone</a>) [<a href="#rid1">1,42</a>]. However, a randomized trial in 154 patients undergoing major thoracic surgery found a similar incidence of AF after postoperative administration of amiodarone compared with placebo [<a href="#rid43">43</a>].</p><p>Further discussion of AF prophylaxis after pulmonary resection is available in a separate topic. (See  <a class="medical medical_review" href="/z/d/html/109433.html" rel="external">"Overview of pulmonary resection", section on 'Preventive measures'</a>.)</p><p class="headingAnchor" id="H2390991500"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/122843.html" rel="external">"Society guideline links: Enhanced recovery after surgery"</a>.)</p><p class="headingAnchor" id="H221727127"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Scope and goals of ERATS programs</strong> – Key recommendations for medical, anesthetic, and surgical management in enhanced recovery after thoracic surgery (ERATS) programs address the entire pathway from preoperative consultation to hospital discharge. Specific goals include reducing opioid use, length of stay in the intensive care unit (ICU) and hospital, morbidity (particularly pulmonary and cardiac morbidity), and costs. Positive effects are greatest when high compliance with all elements of the pathway is achieved. (See <a class="local">'Scope and goals of ERATS programs'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preoperative strategies</strong> – Preoperative elements include identification and correction of anemia  (<a class="graphic graphic_algorithm graphicRef120496" href="/z/d/graphic/120496.html" rel="external">algorithm 1</a>), smoking cessation at least four weeks before surgery, education regarding expectations, and, in selected patients, prehabilitation (eg, nutrition, exercise, and/or respiratory muscle training). (See <a class="local">'Preoperative strategies'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Day of surgery strategies</strong> – Fasting is limited (ie, allow clear fluids up until two hours before and solids until six hours before surgery). Benzodiazepines including <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">midazolam</a> are avoided. (See <a class="local">'Day of surgery strategies'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Intraoperative anesthetic strategies</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Short-acting anesthetics and neuromuscular blocking agents</strong> – Short-acting intravenous (IV) and/or inhalation anesthetic agents and neuromuscular blocking agents are selected to facilitate early emergence and extubation. (See <a class="local">'Use of short-acting anesthetic agents'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Multimodal pain management</strong> – Regional anesthetic techniques (eg, epidural, paravertebral, or serratus anterior plane blocks) and nonopioid analgesics (eg, <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">acetaminophen</a>, nonsteroidal antiinflammatory agents [NSAIDs]) are employed to minimize postoperative opioid use. (See <a class="local">'Multimodal pain management'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Lung-protective ventilation</strong> – We employ lung-protective ventilation strategies during ventilation of one or both lungs. (See  <a class="medical medical_review" href="/z/d/html/14945.html" rel="external">"One lung ventilation: General principles", section on 'Lung-protective ventilation strategies'</a> and  <a class="medical medical_review" href="/z/d/html/93386.html" rel="external">"Mechanical ventilation during anesthesia in adults", section on 'Lung protective ventilation during anesthesia'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Maintain normovolemia</strong> – We employ a "moderate," goal-directed fluid management strategy to maintain normovolemia. A balanced crystalloid solution is selected, and we typically use dynamic parameters to determine fluid responsiveness. (See <a class="local">'Maintenance of normovolemia'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Maintain normothermia</strong> – We maintain normothermia (ie, temperature ≥35.5°C) throughout the perioperative period. (See <a class="local">'Maintenance of normothermia'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Postoperative nausea and vomiting prophylaxis</strong> – We use multimodal antiemetic prophylaxis including a 5-hydroxytryptamine type 3 (5-HT3) antagonist such as IV <a class="drug drug_general" data-topicid="9719" href="/z/d/drug information/9719.html" rel="external">ondansetron</a> combined with a glucocorticoid (eg, <a class="drug drug_general" data-topicid="9334" href="/z/d/drug information/9334.html" rel="external">dexamethasone</a>, <a class="drug drug_general" data-topicid="9639" href="/z/d/drug information/9639.html" rel="external">methylprednisolone</a>). (See <a class="local">'Postoperative nausea and vomiting prophylaxis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Early extubation</strong> – Most patients are extubated in the operating room at the end of the procedure. (See <a class="local">'Early extubation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Postoperative strategies</strong> – Postoperative strategies include early postoperative mobilization, enteral hydration and nutrition, and venous thromboembolism prophylaxis. Prevention of atrial fibrillation (AF) includes continuing chronically administered beta-blockers and ensuring adequate magnesium levels. (See <a class="local">'Postoperative strategies'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Batchelor TJP, Rasburn NJ, Abdelnour-Berchtold E, et al. Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS®) Society and the European Society of Thoracic Surgeons (ESTS). Eur J Cardiothorac Surg 2019; 55:91.</a></li><li><a class="nounderline abstract_t">Haro GJ, Sheu B, Marcus SG, et al. Perioperative Lung Resection Outcomes After Implementation of a Multidisciplinary, Evidence-based Thoracic ERAS Program. Ann Surg 2021; 274:e1008.</a></li><li><a class="nounderline abstract_t">Van Haren RM, Mehran RJ, Mena GE, et al. Enhanced Recovery Decreases Pulmonary and Cardiac Complications After Thoracotomy for Lung Cancer. Ann Thorac Surg 2018; 106:272.</a></li><li><a class="nounderline abstract_t">Martin LW, Sarosiek BM, Harrison MA, et al. Implementing a Thoracic Enhanced Recovery Program: Lessons Learned in the First Year. Ann Thorac Surg 2018; 105:1597.</a></li><li><a class="nounderline abstract_t">Rogers LJ, Bleetman D, Messenger DE, et al. The impact of enhanced recovery after surgery (ERAS) protocol compliance on morbidity from resection for primary lung cancer. J Thorac Cardiovasc Surg 2018; 155:1843.</a></li><li><a class="nounderline abstract_t">Madani A, Fiore JF Jr, Wang Y, et al. An enhanced recovery pathway reduces duration of stay and complications after open pulmonary lobectomy. Surgery 2015; 158:899.</a></li><li><a class="nounderline abstract_t">Li S, Zhou K, Che G, et al. Enhanced recovery programs in lung cancer surgery: systematic review and meta-analysis of randomized controlled trials. Cancer Manag Res 2017; 9:657.</a></li><li><a class="nounderline abstract_t">Forster C, Doucet V, Perentes JY, et al. Impact of Compliance With Components of an ERAS Pathway on the Outcomes of Anatomic VATS Pulmonary Resections. J Cardiothorac Vasc Anesth 2020; 34:1858.</a></li><li><a class="nounderline abstract_t">Brunelli A, Thomas C, Dinesh P, Lumb A. Enhanced recovery pathway versus standard care in patients undergoing video-assisted thoracoscopic lobectomy. J Thorac Cardiovasc Surg 2017; 154:2084.</a></li><li><a class="nounderline abstract_t">Berardi R, Brunelli A, Tamburrano T, et al. Perioperative anemia and blood transfusions as prognostic factors in patients undergoing resection for non-small cell lung cancers. Lung Cancer 2005; 49:371.</a></li><li><a class="nounderline abstract_t">Jean RA, DeLuzio MR, Kraev AI, et al. Analyzing Risk Factors for Morbidity and Mortality after Lung Resection for Lung Cancer Using the NSQIP Database. J Am Coll Surg 2016; 222:992.</a></li><li><a class="nounderline abstract_t">Parsons A, Daley A, Begh R, Aveyard P. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ 2010; 340:b5569.</a></li><li><a class="nounderline abstract_t">Balduyck B, Sardari Nia P, Cogen A, et al. The effect of smoking cessation on quality of life after lung cancer surgery. Eur J Cardiothorac Surg 2011; 40:1432.</a></li><li><a class="nounderline abstract_t">Bilotta F, Lauretta MP, Borozdina A, et al. Postoperative delirium: risk factors, diagnosis and perioperative care. Minerva Anestesiol 2013; 79:1066.</a></li><li><a class="nounderline abstract_t">Makkad B, Heinke TL, Sheriffdeen R, et al. Practice Advisory for Preoperative and Intraoperative Pain Management of Thoracic Surgical Patients: Part 1. Anesth Analg 2023; 137:2.</a></li><li><a class="nounderline abstract_t">Wick EC, Grant MC, Wu CL. Postoperative Multimodal Analgesia Pain Management With Nonopioid Analgesics and Techniques: A Review. JAMA Surg 2017; 152:691.</a></li><li><a class="nounderline abstract_t">Marshall K, McLaughlin K. Pain Management in Thoracic Surgery. Thorac Surg Clin 2020; 30:339.</a></li><li class="breakAll">Pennefather SH, McKevith J. Pain Management After Thoracic Surgery. In: Principles and Practice of Anesthesia for Thoracic Surgery, Slinger P (Ed), Springer, 2011. p.675.</li><li><a class="nounderline abstract_t">Bayman EO, Brennan TJ. Incidence and severity of chronic pain at 3 and 6 months after thoracotomy: meta-analysis. J Pain 2014; 15:887.</a></li><li><a class="nounderline abstract_t">Wang L, Yang M, Meng W. Prevalence and Characteristics of Persistent Postoperative Pain After Thoracic Surgery: A Systematic Review and Meta-Analysis. Anesth Analg 2023; 137:48.</a></li><li><a class="nounderline abstract_t">Remy C, Marret E, Bonnet F. Effects of acetaminophen on morphine side-effects and consumption after major surgery: meta-analysis of randomized controlled trials. Br J Anaesth 2005; 94:505.</a></li><li><a class="nounderline abstract_t">Kaban JM, Kurtz J, Parsikia A, et al. Adherence to non-opioid multimodal analgesia (NOMA) protocol is associated with a shorter length of stay after thoracic surgery. J Clin Anesth 2020; 60:113.</a></li><li><a class="nounderline abstract_t">Bainbridge D, Cheng DC, Martin JE, et al. NSAID-analgesia, pain control and morbidity in cardiothoracic surgery. Can J Anaesth 2006; 53:46.</a></li><li><a class="nounderline abstract_t">Cramer JD, Barnett ML, Anne S, et al. Nonopioid, Multimodal Analgesia as First-line Therapy After Otolaryngology Operations: Primer on Nonsteroidal Anti-inflammatory Drugs (NSAIDs). Otolaryngol Head Neck Surg 2021; 164:712.</a></li><li><a class="nounderline abstract_t">Habibi V, Kiabi FH, Sharifi H. The Effect of Dexmedetomidine on the Acute Pain After Cardiothoracic Surgeries: A Systematic Review. Braz J Cardiovasc Surg 2018; 33:404.</a></li><li><a class="nounderline abstract_t">Michelet P, Guervilly C, Hélaine A, et al. Adding ketamine to morphine for patient-controlled analgesia after thoracic surgery: influence on morphine consumption, respiratory function, and nocturnal desaturation. Br J Anaesth 2007; 99:396.</a></li><li><a class="nounderline abstract_t">Nelson DB, Cata JP, Niu J, et al. Persistent opioid use is associated with worse survival after lobectomy for stage I non-small cell lung cancer. Pain 2019; 160:2365.</a></li><li><a class="nounderline abstract_t">Karamnov S, Muehlschlegel JD. Inflammatory Responses to Surgery and Postoperative Atrial Fibrillation. Anesthesiology 2022; 136:877.</a></li><li><a class="nounderline abstract_t">Blank RS, Colquhoun DA, Durieux ME, et al. Management of One-lung Ventilation: Impact of Tidal Volume on Complications after Thoracic Surgery. Anesthesiology 2016; 124:1286.</a></li><li><a class="nounderline abstract_t">Colquhoun DA, Leis AM, Shanks AM, et al. A Lower Tidal Volume Regimen during One-lung Ventilation for Lung Resection Surgery Is Not Associated with Reduced Postoperative Pulmonary Complications. Anesthesiology 2021; 134:562.</a></li><li><a class="nounderline abstract_t">Şentürk M, Bingül ES, Turhan Ö. Should fluid management in thoracic surgery be goal directed? Curr Opin Anaesthesiol 2022; 35:89.</a></li><li><a class="nounderline abstract_t">Licker M, de Perrot M, Spiliopoulos A, et al. Risk factors for acute lung injury after thoracic surgery for lung cancer. Anesth Analg 2003; 97:1558.</a></li><li><a class="nounderline abstract_t">Alam N, Park BJ, Wilton A, et al. Incidence and risk factors for lung injury after lung cancer resection. Ann Thorac Surg 2007; 84:1085.</a></li><li><a class="nounderline abstract_t">Yao S, Mao T, Fang W, et al. Incidence and risk factors for acute lung injury after open thoracotomy for thoracic diseases. J Thorac Dis 2013; 5:455.</a></li><li><a class="nounderline abstract_t">Licker M, Fauconnet P, Villiger Y, Tschopp JM. Acute lung injury and outcomes after thoracic surgery. Curr Opin Anaesthesiol 2009; 22:61.</a></li><li><a class="nounderline abstract_t">Della Rocca G, Coccia C. Acute lung injury in thoracic surgery. Curr Opin Anaesthesiol 2013; 26:40.</a></li><li><a class="nounderline abstract_t">Eichenbaum KD, Neustein SM. Acute lung injury after thoracic surgery. J Cardiothorac Vasc Anesth 2010; 24:681.</a></li><li><a class="nounderline abstract_t">Assaad S, Popescu W, Perrino A. Fluid management in thoracic surgery. Curr Opin Anaesthesiol 2013; 26:31.</a></li><li><a class="nounderline abstract_t">Zeldin RA, Normandin D, Landtwing D, Peters RM. Postpneumonectomy pulmonary edema. J Thorac Cardiovasc Surg 1984; 87:359.</a></li><li><a class="nounderline abstract_t">Fernández-Pérez ER, Keegan MT, Brown DR, et al. Intraoperative tidal volume as a risk factor for respiratory failure after pneumonectomy. Anesthesiology 2006; 105:14.</a></li><li><a class="nounderline abstract_t">Arslantas MK, Kara HV, Tuncer BB, et al. Effect of the amount of intraoperative fluid administration on postoperative pulmonary complications following anatomic lung resections. J Thorac Cardiovasc Surg 2015; 149:314.</a></li><li><a class="nounderline abstract_t">Fernando HC, Jaklitsch MT, Walsh GL, et al. The Society of Thoracic Surgeons practice guideline on the prophylaxis and management of atrial fibrillation associated with general thoracic surgery: executive summary. Ann Thorac Surg 2011; 92:1144.</a></li><li><a class="nounderline abstract_t">Amar D, Zhang H, Chung MK, et al. Amiodarone with or without N-Acetylcysteine for the Prevention of Atrial Fibrillation after Thoracic Surgery: A Double-blind, Randomized Trial. Anesthesiology 2022; 136:916.</a></li></ol></div><div id="topicVersionRevision">Topic 138418 Version 7.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30304509" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS®) Society and the European Society of Thoracic Surgeons (ESTS).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31851005" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Perioperative Lung Resection Outcomes After Implementation of a Multidisciplinary, Evidence-based Thoracic ERAS Program.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29530770" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Enhanced Recovery Decreases Pulmonary and Cardiac Complications After Thoracotomy for Lung Cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29510097" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Implementing a Thoracic Enhanced Recovery Program: Lessons Learned in the First Year.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29352586" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : The impact of enhanced recovery after surgery (ERAS) protocol compliance on morbidity from resection for primary lung cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26189953" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : An enhanced recovery pathway reduces duration of stay and complications after open pulmonary lobectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29180901" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Enhanced recovery programs in lung cancer surgery: systematic review and meta-analysis of randomized controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32139340" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Impact of Compliance With Components of an ERAS Pathway on the Outcomes of Anatomic VATS Pulmonary Resections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28728783" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Enhanced recovery pathway versus standard care in patients undergoing video-assisted thoracoscopic lobectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15951051" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Perioperative anemia and blood transfusions as prognostic factors in patients undergoing resection for non-small cell lung cancers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27118714" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Analyzing Risk Factors for Morbidity and Mortality after Lung Resection for Lung Cancer Using the NSQIP Database.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20093278" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21498082" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : The effect of smoking cessation on quality of life after lung cancer surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23511351" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Postoperative delirium: risk factors, diagnosis and perioperative care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37079466" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Practice Advisory for Preoperative and Intraoperative Pain Management of Thoracic Surgical Patients: Part 1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28564673" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Postoperative Multimodal Analgesia Pain Management With Nonopioid Analgesics and Techniques: A Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32593366" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Pain Management in Thoracic Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32593366" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Pain Management in Thoracic Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24968967" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Incidence and severity of chronic pain at 3 and 6 months after thoracotomy: meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37326863" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Prevalence and Characteristics of Persistent Postoperative Pain After Thoracic Surgery: A Systematic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15681586" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Effects of acetaminophen on morphine side-effects and consumption after major surgery: meta-analysis of randomized controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31634765" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Adherence to non-opioid multimodal analgesia (NOMA) protocol is associated with a shorter length of stay after thoracic surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16371609" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : NSAID-analgesia, pain control and morbidity in cardiothoracic surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32806991" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Nonopioid, Multimodal Analgesia as First-line Therapy After Otolaryngology Operations: Primer on Nonsteroidal Anti-inflammatory Drugs (NSAIDs).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30184039" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : The Effect of Dexmedetomidine on the Acute Pain After Cardiothoracic Surgeries: A Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17576969" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Adding ketamine to morphine for patient-controlled analgesia after thoracic surgery: influence on morphine consumption, respiratory function, and nocturnal desaturation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31149979" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Persistent opioid use is associated with worse survival after lobectomy for stage I non-small cell lung cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35482968" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Inflammatory Responses to Surgery and Postoperative Atrial Fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27011307" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Management of One-lung Ventilation: Impact of Tidal Volume on Complications after Thoracic Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33635945" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : A Lower Tidal Volume Regimen during One-lung Ventilation for Lung Resection Surgery Is Not Associated with Reduced Postoperative Pulmonary Complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34889800" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Should fluid management in thoracic surgery be goal directed?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14633519" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Risk factors for acute lung injury after thoracic surgery for lung cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17888952" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Incidence and risk factors for lung injury after lung cancer resection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23991302" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Incidence and risk factors for acute lung injury after open thoracotomy for thoracic diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19295294" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Acute lung injury and outcomes after thoracic surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23235524" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Acute lung injury in thoracic surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20060320" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Acute lung injury after thoracic surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23262471" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Fluid management in thoracic surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6700243" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Postpneumonectomy pulmonary edema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16809989" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Intraoperative tidal volume as a risk factor for respiratory failure after pneumonectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25304302" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Effect of the amount of intraoperative fluid administration on postoperative pulmonary complications following anatomic lung resections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21871327" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : The Society of Thoracic Surgeons practice guideline on the prophylaxis and management of atrial fibrillation associated with general thoracic surgery: executive summary.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35263434" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Amiodarone with or without N-Acetylcysteine for the Prevention of Atrial Fibrillation after Thoracic Surgery: A Double-blind, Randomized Trial.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
